No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US Stock MarketDetailed Quotes
SANA Sana Biotechnology
- 1.650
- +0.050+3.13%
Close Dec 20 16:00 ET
- 1.720
- +0.070+4.24%
Post 18:59 ET
368.39MMarket Cap-1.18P/E (TTM)
1.720High1.550Low3.20MVolume1.590Open1.600Pre Close5.28MTurnover2.45%Turnover RatioLossP/E (Static)223.27MShares12.00052wk High1.26P/B216.01MFloat Cap1.55052wk Low--Dividend TTM130.91MShs Float44.600Historical High--Div YieldTTM10.63%Amplitude1.550Historical Low1.649Avg Price1Lot Size
Full Hours
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Sana Biotechnology (NASDAQ:SANA) Will Have To Spend Its Cash Wisely
Sana Biotechnology (SANA) Receives a Buy From Morgan Stanley
Express News | Sana Biotechnology Inc - Expect to Report Initial Clinical Data in 2025 in Gleam Trial for Sc291 in B-Cell Mediated Autoimmune Diseases
Express News | Sana Biotechnology Announces Fast Track Designation for Sc291 in Relapsed/Refractory Systemic Lupus Erythematosus
Sana Biotechnology Announces Fast Track Designation for SC291 in Relapsed/Refractory Systemic Lupus Erythematosus
Sana Biotechnology to Present at December 2024 Investor Conferences
Heat List
US
Overall
Symbol
Price
% Chg
No Data